Evaluation of Coffee Therapy for Improvement of Renal Oxygenation

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

January 21, 2020

Study Completion Date

September 30, 2021

Conditions
Type1diabetesType1 Diabetes MellitusDiabetic Kidney DiseaseJuvenile DiabetesDiabetic NephropathiesDiabetes ComplicationsDiabetes, Autoimmune
Interventions
DRUG

Starbucks® Cold brew - 325ml bottle

Starbucks® Cold brew 325ml bottles daily \[205mg caffeine\] will be provided to the participants. Participants will be instructed to drink 1 bottle every morning between 6 and 9 am for 6 days prior to the post-intervention visit. The 7th day is the post-intervention visit, and participants will be asked to drink 1 bottle the morning of the study visit

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

lead

University of Colorado, Denver

OTHER

NCT03878277 - Evaluation of Coffee Therapy for Improvement of Renal Oxygenation | Biotech Hunter | Biotech Hunter